drugset
drugset / Trial / NCT00984581

Safety and Efficacy Study of Avotermin (Juvista) in Female Subjects

NCT00984581 ↗

Phase 1/2 Completed 35 enrolled Renovo
RandomizedParallel-groupQuadruple-blindPrevention

Summary

To assess safety and toleration, systemic exposure and anti-scarring potential of intradermal avotermin (Juvista) in young females.

Timeline

Start
2003-04
Primary completion
2004-08
Completion
2004-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Avotermin Protein / enzyme biologic 5 ng Other
Subject Avotermin Protein / enzyme biologic 50 ng Other

Indications

No indication recorded.